All articles by Amit Thadani
Amit Thadani
Cepheid’s Multi-Target Test Design Enables Detection of Influenza Variants
SUNNYVALE, Calif. — Currently circulating mutant strains of influenza highlight the need for multi-target diagnostic tests. Two recently identified mutations in the matrix genes of the Human Influenza A virus have been reported to cause matrix gene target failure (MGTF) for several commercial diagnostic tests1. Cepheid’s respiratory test design enables detection of these new variants, and with similar symptoms across various illnesses such as the flu, respiratory syncytial virus (RSV) disease, and COVID-19, an accurate and fast diagnosis is critical to patient care.
Mindray Celebrates Opening Of Expanded Nashville Experience Center
Global developer of innovative healthcare solutions celebrated the Grand Opening of their newly-expanded Nashville Experience Center with a ribbon cutting ceremony – attendees included healthcare leaders and decision-makers in Nashville.
Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patients with atrial fibrillation
SPHERE Per-AF will determine the safety and effectiveness of the Sphere-9 cardiac ablation and mapping catheter with the Affera mapping and navigation system
#6 KinetikOS is now FDA-listed | MEDICA 22 | 1st World Movement Disorders Day
First scientific-backed technology to assess movement in continuum even without wearables
Pioneering remote monitoring platform helps Parkinson’s Nurses to prioritize patients and eases the burden on nurses.
Award-winning new digital technology, with UK operations in Sheffield was exhibited at PDNSA Conference (Parkinson’s Disease Nurse Specialist Association) between the 11-12th Oct, which brought together nurses nationally.
Certest renews its corporate identity
MEDICA 2022, the world’s largest exhibition event for the health sector, has been the starting point chosen by the firm to introduce its new corporate identity.
Cepheid Receives CE Mark for Xpert® Xpress GBS
Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus testing for pregnant females
Mindray Partners With Randox on the New Chemistry Parameters
Mindray, a world-leading developer, manufacturer and supplier of medical devices and solutions, is pleased to announce a partnership with Randox, a global market leader in the in-vitro diagnostics industry committed to revolutionizing healthcare on a global scale, in providing new biochemistry parameters for global customers.
Boston Scientific Expands Diagnostics Offerings in Europe with Launch of LUX-Dx™ Insertable Cardiac Monitor System
Dual-stage algorithm detects and verifies potential heart arrhythmias to help increase clinical efficiency
DIASORIN COMMERCIALIZES MOLECULAR REAGENT FOR MONKEYPOX VIRUS
Saluggia, Italy – DiaSorin (FTSE MIB: DIA) announces its release of an Analyte Specific Reagent (ASR) primer pair that detects the B17R/B18R gene of the monkeypox virus, the orthopoxvirus responsible for the ongoing 2022 global public health emergency.